Group strategy

1. To characterize the molecular alterations of the troponin molecule in the blood in various clinical conditions such as myocardial stunning, acute coronary syndromes, end-stage renal failure and stroke
2. To examine the hemodynamics, tissue-doppler characteristics and release of myocardial markers in acute heart failure
3. To assess the impact of exogenous androgenic steroid abuse (doping) on cardiovascular risk profile and function